Skip to main content
. 2020 Jul 28;7:366. doi: 10.3389/fmed.2020.00366

Figure 1.

Figure 1

Computed tomography of the ovary before and after initiation of nivolumab treatment. (A) Tumor status before treatment, (B) Pseudo-progression within the first 2 months of treatment, (C) Partial response after treatment, (D) Progression.